How AI Designs New Protein Sequences for Specific Shapes
This patent describes a method where a computer-powered neural network fills in missing parts of a protein's amino acid sequence, ensuring the final protein has a desired 3D shape or "fold structure."
Original patent title: “System and method for generating a protein sequence”
This patent describes a method where a computer-powered neural network fills in missing parts of a protein's amino acid sequence, ensuring the final protein has a desired 3D shape or "fold structure.". Granted to University of Toronto in 2026 with 22 claims and 1 forward citation, and it is expected to expire in 2040.
Coverage
What does this patent actually cover?
The patent describes a computer-based method for designing protein sequences. It starts by taking an incomplete list of amino acids (called "node elements") for a protein and a map of how these amino acids should physically interact to form a specific 3D shape (an "edge index" defining a "desired fold structure"). A neural network then processes this information. It first figures out improved details about the interactions between amino acids ("enhanced edge attribute values") based on the known amino acids. Then, it uses these improved interaction details to determine better amino acid characteristics ("enhanced amino acid values") for each position. Finally, for any amino acid positions that were initially missing, the network generates the specific amino acid that should go there, completing the protein sequence to match the desired shape. For example, if you wanted a protein with a specific binding pocket, you could provide the known amino acids around that pocket and the desired distances between them, and the network would fill in the rest of the sequence.
The gap
What does this patent NOT cover?
- Does not cover generating protein sequences without defining a desired physical interaction or "fold structure" beforehand.
- Does not cover methods that predict a protein's 3D structure from an existing amino acid sequence.
- Does not cover protein design approaches that do not use a computer-implemented neural network.
- Does not cover generating protein sequences without an iterative refinement process of edge and node attributes.
- Does not cover designing proteins where the "edge attribute value set" does not represent a characteristic of physical interaction, such as a Euclidean distance.
These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.
Key facts
What made this novel
The noveltynoveltyThe requirement that an invention be different from anything publicly known before its priority date.Read more → lies in the iterative refinement process where the neural network simultaneously enhances both the understanding of physical interactions (edge attributes) and the characteristics of individual amino acids (node attributes) based on a desired 3D structure. This allows it to fill in missing amino acids while ensuring the generated sequence is consistent with the target fold.
The Patent Drawing

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.
Where you've seen this
Real-world examples
Designing novel enzymes for industrial processes
Creating new therapeutic proteins with specific binding sites
Developing custom antibodies
Engineering proteins for biosensors
Designing stable protein scaffolds for drug delivery
Why it matters
The bigger picture
Proteins are the workhorses of biology, performing nearly all cellular functions. Being able to design new protein sequences that reliably fold into specific, desired 3D shapes is crucial for developing new drugs, enzymes, and biomaterials. This technology could accelerate the discovery of novel therapeutics or industrial catalysts by allowing researchers to computationally explore a vast space of potential protein designs.
Filed
December 4, 2020
Granted
June 16, 2026
Market context
Who's building on this
Companies in this space
Major pharmaceutical companies and biotech startups are heavily investing in AI-driven protein design. Companies like DeepMind (Alphabet), Generate Biomedicines, and Insilico Medicine are actively developing and applying machine learning models for de novo protein design and optimization. Academic institutions, including the University of Toronto (the assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →), continue to be at the forefront of this research.
Market impact
This type of technology is transforming drug discovery and materials science. It enables the creation of novel proteins with tailored functions, potentially leading to new classes of therapeutics, vaccines, and industrial enzymes. By accelerating the design process, it significantly reduces the time and cost associated with traditional protein engineering, opening up new market opportunities for custom-designed biological molecules.
Claim 1 — Plain English
What this patent covers
The patent describes a computer-based method for designing protein sequences. It starts by taking an incomplete list of amino acids (called "node elements") for a protein and a map of how these amino acids should physically interact to form a specific 3D shape (an "edge index" defining a "desired fold structure"). A neural network then processes this information. It first figures out improved details about the interactions between amino acids ("enhanced edge attribute values") based on the known amino acids. Then, it uses these improved interaction details to determine better amino acid characteristics ("enhanced amino acid values") for each position. Finally, for any amino acid positions that were initially missing, the network generates the specific amino acid that should go there, completing the protein sequence to match the desired shape. For example, if you wanted a protein with a specific binding pocket, you could provide the known amino acids around that pocket and the desired distances between them, and the network would fill in the rest of the sequence.
The clever bit
The novelty lies in the iterative refinement process where the neural network simultaneously enhances both the understanding of physical interactions (edge attributes) and the characteristics of individual amino acids (node attributes) based on a desired 3D structure. This allows it to fill in missing amino acids while ensuring the generated sequence is consistent with the target fold.
What it does not cover
- Does not cover generating protein sequences without defining a desired physical interaction or "fold structure" beforehand.
- Does not cover methods that predict a protein's 3D structure from an existing amino acid sequence.
- Does not cover protein design approaches that do not use a computer-implemented neural network.
- Does not cover generating protein sequences without an iterative refinement process of edge and node attributes.
- Does not cover designing proteins where the "edge attribute value set" does not represent a characteristic of physical interaction, such as a Euclidean distance.
Patent timeline
Application submitted to the patent office
Application published, typically 18 months after filing
Patent officially issued
Patent enters public domain
PatentBrief Score
Impact Score
Strong
Citation count
6/40
Early citations
Claim breadth
15/20
Broad claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →
Recency
20/20
Granted within 5 years
Assignee scale
20/20
Major company or institution
PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.
Heuristic Value Estimate
What this patent might be worth
$94K – $300K
Midpoint $187K · 14.0 yr remaining · industry ×2.0
Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.
Claim text not yet imported for this patent
The original legal language
Original claims
22 claims as filed with the patent office.
Concepts involved
Citations
Patent lineage
Cite this patent
STROKACH, A. V., KIM, P. M., ROMERO, D. B., VERGE, C. C., & Riba, A. P. (2026). How AI Designs New Protein Sequences for Specific Shapes (U.S. Patent No. 12,655,176). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/12655176/system-and-method-for-generating-a-protein-sequence
Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.
Embed
Add this patent to your site
Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.
<div data-patentlens-widget data-patent-number="US12655176"></div> <script src="https://patentbrief.org/embed.js" async></script>
Stay in the loop
Get a weekly digest of new patents.
One email per week. No spam. Unsubscribe anytime.
Keep exploring
Related patents you should know
US 4683195 · 1987
How to Make Billions of Copies of a DNA Segment
This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.
Cetus Corp
US 8697359 · 2014
How to Edit Genes in Human Cells Using an Engineered CRISPR System
This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.
Massachusetts Institute of Technology
US 7657849 · 2010
How the iPhone's Slide-to-Unlock Gesture Works
Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.
Apple Inc
US 4733665 · 1988
How Doctors Implant a Permanent Stent Using a Balloon
This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.
Expandable Grafts Partnership
US 4965188 · 1990
How to Make Many Copies of a DNA Piece with Heat
This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.
Cetus Corp
US 4235871 · 1980
How to Encapsulate Active Materials in Lipid Bubbles Efficiently
This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.
Individual
Semantically similar
You might also find these interesting
US 12603151 · 2026 · Florida State University Research Foundation
Using AI to Design and Predict Protein Structures
US 12412637 · 2025 · International Business Machines
Computer Model Designs Proteins by Matching Structure to Sequence
US 12437843 · 2025 · GDM Holding
Using AI to Predict Protein Shapes for Drug Discovery
US 20240412809 · DeepMind Technologies
AI Predicts 3D Protein Shapes from Genetic Code
More to explore
More in Biotech & Medicine
US 4683195 · 1987 · Cetus Corp
How to Make Billions of Copies of a DNA Segment
US 8697359 · 2014 · Massachusetts Institute of Technology
How to Edit Genes in Human Cells Using an Engineered CRISPR System
US 4733665 · 1988 · Expandable Grafts Partnership
How Doctors Implant a Permanent Stent Using a Balloon
US 4965188 · 1990 · Cetus Corp
How to Make Many Copies of a DNA Piece with Heat
New to patents?
Common Questions
Frequently Asked Questions
What does How AI Designs New Protein Sequences for Specific Shapes cover?
This patent describes a method where a computer-powered neural network fills in missing parts of a protein's amino acid sequence, ensuring the final protein has a desired 3D shape or "fold structure."
Who owns patent US 12655176?
University of Toronto owns this patent, granted in 2026.
When does this patent expire?
This patent is expected to expire on December 4, 2040, when the invention enters the public domain.
What is patent US 12655176 cited by?
This patent has been cited by 1 later patents that build on its ideas.
What problem does this patent solve?
Proteins are the workhorses of biology, performing nearly all cellular functions. Being able to design new protein sequences that reliably fold into specific, desired 3D shapes is crucial for developing new drugs, enzymes, and biomaterials. This technology could accelerate the discovery of novel therapeutics or industrial catalysts by allowing researchers to computationally explore a vast space of potential protein designs.
What does this patent NOT cover?
Does not cover generating protein sequences without defining a desired physical interaction or "fold structure" beforehand.
Same assignee
More from University of Toronto
Patent monitoring



